MIRA Pharmaceuticals, Inc. (MIRA) vs Rockwell Medical, Inc. (RMTI)
A side-by-side comparison of MIRA Pharmaceuticals, Inc. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MIRA
MIRA Pharmaceuticals, Inc.
$0.73HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
RMTI
Rockwell Medical, Inc.
$8.18HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Total return — MIRA vs RMTI
growth of $100 · dividends reinvested · last 3yMIRA -88.5% (-51.4%/yr)RMTI -73.2% (-35.5%/yr)RMTI compounded faster over this window
MIRA RMTI
MIRA vs RMTI: by the numbers
- •RMTI is the larger company ($32M vs $31M market cap).
- •Both run net losses; MIRA's is the smaller (0.00% vs -7.33% net margin).
Metrics side by side
Valuation
| Metric | MIRA | RMTI |
|---|---|---|
| P/S ratio | N/A | 0.47 |
| P/B ratio | 3.76 | 0.92 |
| FCF yield | N/A | 4.77% |
Profitability
| Metric | MIRA | RMTI |
|---|---|---|
| Gross margin | 0.00% | 17.71% |
| Operating margin | 0.00% | -6.52% |
| Net margin | 0.00% | -7.33% |
| ROE | -116.14% | -14.49% |
| ROIC | -115.18% | -9.60% |
Growth (annualized)
| Metric | MIRA | RMTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.59% |
| Total return CAGR (5Y) | N/A | -33.38% |
Go deeper
Dig into the metrics
MIRA Pharmaceuticals ROERockwell Medical ROEMIRA Pharmaceuticals operating marginRockwell Medical operating marginMIRA Pharmaceuticals revenue growthRockwell Medical revenue growthMIRA Pharmaceuticals free cash flowRockwell Medical free cash flow
MIRA Pharmaceuticals & Rockwell Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.